A Texas cell therapy company is restarting its clinical testing and setting up shop in Massachusetts after becoming the first company to work with new venture capital firm ElevateBio.

Cambridge-based ElevateBio was launched last week by three former Alexion Pharmaceuticals and bluebird bio executives, who raised $150 million to found and invest in cell and gene therapy companies.  

ElevateBio has now disclosed its first venture: AlloVir, formerly called ViraCyte, which is developing single-dose…

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/05/22/new-cambridge-vc-firm-elevatebios-first-investment.html?ana=RSS&s=article_search